Castle Biosciences to Participate in Upcoming Investor Conferences

Castle Biosciences (Nasdaq: CSTL) will present a company overview at Baird's 2026 Global Healthcare Conference on Tuesday, Sept. 15, 2026, at 10:50 a.m. Eastern time, with a live audio webcast and replay available on its investor relations website.

Rhea-AI Summary

Castle Biosciences (Nasdaq: CSTL) will present a company overview at Baird's 2026 Global Healthcare Conference on Tuesday, Sept. 15, 2026, at 10:50 a.m. Eastern time, with a live audio webcast and replay available on its investor relations website. The company will also participate in one-on-one investor meetings at the 10th annual Lake Street Best Ideas Growth (BIG10) Conference on Thursday, Sept. 10, 2026, with meetings requested exclusively through Lake Street Capital Markets.

Argus Aug 20 session 15 alerts

+1.89% close to close 1.1x rel. volume Open Argus

Details

News Market Reaction – CSTL

$1.04B Mkt Cap at Peak Alert

On Aug 20, the day this news came out, CSTL closed 1.89% above the previous close. Our momentum scanner recorded 15 alerts for this stock that day.

Data tracked by StockTitan Argus for the Aug 20 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRIENDSWOOD, Texas, Aug. 20, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird's 2026 Global Healthcare Conference on Tuesday, Sept. 15, 2026, at 10:50 a.m. Eastern time.

A live audio webcast of the Company's presentation will be available by visiting Castle Biosciences' website at https://ir.castlebiosciences.com/news-events/ir-events. A replay of the webcast will be available following the conclusion of the live broadcast.

Castle will also be available for one-on-one investor meetings during the 10^th annual Lake Street Best Ideas Growth (BIG10) Conference on Thursday, Sept. 10, 2026. Meetings may be requested exclusively through Lake Street Capital Markets.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, Esopredict, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com 

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/castle-biosciences-to-participate-in-upcoming-investor-conferences-302855676.html

SOURCE Castle Biosciences, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Castle Biosciences (CSTL) present at Baird's 2026 Global Healthcare Conference?

Castle Biosciences is scheduled to present at Baird's 2026 Global Healthcare Conference on Tuesday, Sept. 15, 2026, at 10:50 a.m. Eastern time. According to the company, this presentation will feature a company overview for investors.

How can investors access the Castle Biosciences (CSTL) webcast on September 15, 2026?

Investors can access the live audio webcast by visiting Castle Biosciences' investor relations events page. According to the company, a replay of the webcast will be available after the live broadcast concludes for on-demand listening.

Will there be a replay of Castle Biosciences' Baird 2026 conference presentation for CSTL shareholders?

Yes, a replay of Castle Biosciences' Baird 2026 conference presentation will be available. According to the company, the replay can be accessed on its investor relations website following the conclusion of the live audio webcast.

What is Castle Biosciences' involvement in the Lake Street Best Ideas Growth (BIG10) Conference 2026?

Castle Biosciences will be available for one-on-one investor meetings at the 10th annual Lake Street BIG10 Conference on Thursday, Sept. 10, 2026. According to the company, meetings may be requested exclusively through Lake Street Capital Markets.

How can investors request one-on-one meetings with Castle Biosciences (CSTL) at the 2026 Lake Street BIG10 Conference?

Investors must request one-on-one meetings with Castle Biosciences exclusively through Lake Street Capital Markets. According to the company, these meetings will occur during the 10th annual Lake Street Best Ideas Growth (BIG10) Conference on September 10, 2026.